跳至主要内容
临床试验/IRCT20180922041089N3
IRCT20180922041089N3已完成3 期

The effect of vitamin D supplements on benign hypertrophy

Tehran University of Medical Sciences0 个研究点目标入组 54 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
54

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50 years 至 no limit(—)
性别
Male

入选标准

  • Man over 50 years old
  • Asymptomatic or mild symptoms of benign prostatic hypertrophy based on the IPSS questionnaire.
  • Patients with benign prostatic hypertrophy

排除标准

  • BMI greater than 35 or pathologic weight loss (weight loss over 10% of body weight in the last 6 months)
  • History of kidney stones, bladder and urinary tract
  • Having prostate or bladder cancer or prostate surgery
  • Acute or chronic prostatitis or frequent urinary tract infections•
  • History of acute urinary retention or repeated catheters in the last three months
  • Use of GnRH agonists, anti-androgens and any hormonal drug in the past six months, the use of herbal and non-herbal medicines to control and treat BPH
  • The history of chronic diseases such as CVA, HTN, COPD, liver and kidney disease, and cancers ..
  • Taking medications that affect vitamin D metabolism such as corticosteroids, phenytoin, phenobarbital, or regular use of vitamin D supplements over the past 3 months
  • Taking diuretics such as Lasix and ...
  • Alcohol consumption

研究者

相似试验

The effect of vitamin D on the treatment of prostate... | 临床试验